Taurine and its derivatives alter brain dopamine metabolism similarly to GABA in mice and rats.
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001581:Benzothiadiazines / Q000494:pharmacology; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism*; D007274:Injections, Intraperitoneal; D007276:Injections, Intraventricular; D008032:Limbic System / Q000187:drug effects / Q000378:metabolism; D051379:Mice; D051381:Rats; D013654:Taurine / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology*; D005680:gamma-Aminobutyric Acid / Q000494:pharmacology*
D001581:Benzothiadiazines; D013654:Taurine; D005680:gamma-Aminobutyric Acid; C001355:tramiprosate; C023986:pivaloyltaurine; C032946:6-aminomethyl-3-methyl-4H-1,2,4-benzothiadiazine 1,1-dioxide; D001058:Apomorphine; D004298:Dopamine